ATE401895T1 - Antipruritisches mittel - Google Patents

Antipruritisches mittel

Info

Publication number
ATE401895T1
ATE401895T1 AT03784565T AT03784565T ATE401895T1 AT E401895 T1 ATE401895 T1 AT E401895T1 AT 03784565 T AT03784565 T AT 03784565T AT 03784565 T AT03784565 T AT 03784565T AT E401895 T1 ATE401895 T1 AT E401895T1
Authority
AT
Austria
Prior art keywords
antipruritic agent
antipruritic
agent
evoked
administering
Prior art date
Application number
AT03784565T
Other languages
English (en)
Inventor
Fumie Sato
Iwao Arai
Norikazu Takano
Tohru Tanami
Makoto Yagi
Original Assignee
Taisho Pharmaceutical Co Ltd
Fumie Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Fumie Sato filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE401895T1 publication Critical patent/ATE401895T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
AT03784565T 2002-08-09 2003-08-07 Antipruritisches mittel ATE401895T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002234011 2002-08-09

Publications (1)

Publication Number Publication Date
ATE401895T1 true ATE401895T1 (de) 2008-08-15

Family

ID=31711882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784565T ATE401895T1 (de) 2002-08-09 2003-08-07 Antipruritisches mittel

Country Status (17)

Country Link
US (1) US7718701B2 (de)
EP (1) EP1527781B1 (de)
JP (1) JP3678366B2 (de)
KR (1) KR100904583B1 (de)
CN (1) CN100408039C (de)
AT (1) ATE401895T1 (de)
AU (1) AU2003254850B2 (de)
CA (1) CA2465103C (de)
DE (1) DE60322395D1 (de)
DK (1) DK1527781T3 (de)
ES (1) ES2309380T3 (de)
MX (1) MXPA04004371A (de)
NO (1) NO20042053L (de)
PL (1) PL373819A1 (de)
PT (1) PT1527781E (de)
TW (1) TW200404053A (de)
WO (1) WO2004014394A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
AU2003280977B2 (en) * 2002-07-12 2008-10-23 Fumie Sato Prostaglandin derivatives
ATE401895T1 (de) 2002-08-09 2008-08-15 Taisho Pharmaceutical Co Ltd Antipruritisches mittel
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
EP1852120A1 (de) 2005-02-14 2007-11-07 Taisho Pharmaceutical Co., Ltd Salbe
CA2624141C (en) 2005-10-03 2014-07-08 Nippon Shinyaku Co., Ltd. Quinazoline derivative and pharmaceutical
WO2008018592A1 (en) 2006-08-11 2008-02-14 Taisho Pharmaceutical Co., Ltd. External preparation comprising prostaglandin derivative
EP2172202A4 (de) 2007-06-29 2010-06-30 Taisho Pharmaceutical Co Ltd Ein prostagland-derivat enthaltendes wässriges flüssiges mittel

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4983629A (en) 1983-07-08 1991-01-08 Schering Aktiengesellschaft 11-haloprostane derivatives, processes for their preparation and their use as medicinal agents
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5891910A (en) 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
JP2716986B2 (ja) * 1987-07-17 1998-02-18 シエーリング アクチエンゲゼルシヤフト ９‐ハロゲン‐（ｚ）‐プロスタグランジン誘導体、その製法及び薬剤としてのその使用
US5591446A (en) 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5252602A (en) 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
WO1993015739A1 (fr) 1992-02-07 1993-08-19 Kaken Pharmaceutical Co., Ltd. Remede destine aux blessures ou aux hemorroides
KR100266834B1 (ko) * 1992-07-24 2000-09-15 우에하라 아끼라 프로스타글란딘 유도체
WO1994008959A1 (fr) * 1992-10-20 1994-04-28 Taisho Pharmaceutical Co., Ltd. Derive de prostaglandine
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3573482B2 (ja) * 1994-03-07 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5807892A (en) 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
AU3936495A (en) * 1994-11-30 1996-06-19 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivative
JPH0971539A (ja) 1995-09-08 1997-03-18 Mochida Pharmaceut Co Ltd 外用鎮痒剤
JPH09169638A (ja) 1995-10-18 1997-06-30 Sekisui Chem Co Ltd 皮膚疾患治療用外用剤
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
JPH09286775A (ja) * 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
WO1997045114A1 (en) 1996-05-30 1997-12-04 Lysis Corporation The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
DE69735552T3 (de) 1996-12-23 2009-08-13 S.L.A. Pharma Ag Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
NO317155B1 (no) 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
JPH10316564A (ja) 1997-05-21 1998-12-02 Sekisui Chem Co Ltd 鎮痒鎮痛外用剤
JPH1180031A (ja) 1997-07-14 1999-03-23 Sekisui Chem Co Ltd 外用剤及び経皮又は経粘膜吸収性を増進する方法
JPH11199478A (ja) * 1998-01-05 1999-07-27 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の抗炎症薬としての使用
CA2333038C (en) * 1998-05-25 2008-12-02 Taisho Pharmaceutical Co., Ltd. Sleep-inducing preparation
ES2241283T3 (es) 1998-06-03 2005-10-16 SHIONOGI &amp; CO., LTD. Remedios para el tratamiento del prurito que contienen antagonistas de pgd2.
US6506789B2 (en) 1998-06-03 2003-01-14 Shionogi & Co., Ltd. Methods for the treatment of itching comprising administering PGD2 receptor antagonist
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
WO2000031290A1 (en) 1998-11-23 2000-06-02 Proteome Sciences, Inc. Methods and compositions for pain management
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
JP2000273083A (ja) * 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
JP2001089443A (ja) * 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
ES2337981T3 (es) 1999-09-10 2010-05-03 Taisho Pharmaceutical Co., Ltd Derivados de prostaglandina.
CA2384783A1 (en) 1999-09-14 2001-03-22 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JP2001122786A (ja) * 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd 睡眠誘発剤
JP2001151749A (ja) * 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP1308162A1 (de) * 1999-11-24 2003-05-07 Taisho Pharmaceutical Co., Ltd Pernasale zusammensetzung
KR20020067594A (ko) 2000-01-05 2002-08-22 오노 야꾸힝 고교 가부시키가이샤 5-티아-ω-치환 페닐-프로스타글란딘 Ｅ-알콜, 이들의제조 방법 및 이들을 유효 성분으로서 함유하는 약제
JP2001220355A (ja) 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2002016311A1 (en) * 2000-08-22 2002-02-28 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
WO2002020462A1 (en) * 2000-09-01 2002-03-14 Ono Pharmaceutical Co., Ltd. Benzoic acid derivatives and drugs containing the same as the active ingredient
AU2002229611A1 (en) 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
US20040266880A1 (en) 2002-02-22 2004-12-30 Fumie Sato Antipruritics
WO2003070252A1 (fr) * 2002-02-22 2003-08-28 Taisho Pharmaceutical Co., Ltd. Agents antiprurigineux
ATE401895T1 (de) 2002-08-09 2008-08-15 Taisho Pharmaceutical Co Ltd Antipruritisches mittel
US7737182B2 (en) 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis

Also Published As

Publication number Publication date
JP3678366B2 (ja) 2005-08-03
TW200404053A (en) 2004-03-16
EP1527781B1 (de) 2008-07-23
WO2004014394A1 (ja) 2004-02-19
TWI328574B (de) 2010-08-11
HK1076391A1 (zh) 2006-01-20
CN100408039C (zh) 2008-08-06
CA2465103C (en) 2011-04-26
EP1527781A1 (de) 2005-05-04
ES2309380T3 (es) 2008-12-16
MXPA04004371A (es) 2004-08-13
CN1620297A (zh) 2005-05-25
US7718701B2 (en) 2010-05-18
CA2465103A1 (en) 2004-02-19
AU2003254850B2 (en) 2008-05-15
NO20042053L (no) 2004-05-18
KR20050026375A (ko) 2005-03-15
DE60322395D1 (de) 2008-09-04
PT1527781E (pt) 2008-08-12
KR100904583B1 (ko) 2009-06-25
US20050009917A1 (en) 2005-01-13
DK1527781T3 (da) 2008-11-17
EP1527781A4 (de) 2006-12-13
JPWO2004014394A1 (ja) 2005-12-02
PL373819A1 (en) 2005-09-19
AU2003254850A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
ATE441418T1 (de) Verwendung von treprostinil zur verbesserung der nierenfunktion
EP1485360A4 (de) Natriumkanalblocker
ATE504315T1 (de) Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
EA201890903A1 (ru) Соединения пиридиловых ингибиторов передачи сигналов белком hedgehog, способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе
DE69732868D1 (de) Mittel gegen Juckreiz
TW200510397A (en) Conjugated complement cascade inhibitors
BR0312099A (pt) Uso de toxina bolutìnica, bem como composição farmacêutica
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
EA200600197A1 (ru) Получение производных соединения 1,3-дифенилпроп-2-ен-1-он
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
NO20065320L (no) Imidazolderivater anvendt som tafiainhibitorer
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
DE60322395D1 (de) Antipruritisches mittel
DE60329326D1 (de) Tace inhibitoren
EA199900948A1 (ru) Способ получения 2-арил-3-арил-5-галогенпиридинов, используемых в качестве ингибиторов cox-2
DE602004028493D1 (de) Isochinolinon-kaliumkanalinhibitoren
SE0200198D0 (sv) New use
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
SE0301883D0 (sv) New use II
EA200001140A1 (ru) СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1527781

Country of ref document: EP